摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3-bis(dimethoxyphosphoryl)-propanoic acid | 959601-54-8

中文名称
——
中文别名
——
英文名称
3,3-bis(dimethoxyphosphoryl)-propanoic acid
英文别名
3,3-bis(dimethoxyphosphory)propanoic acid;3,3-Bis(dimethoxyphosphoryl)propanoic acid;3,3-bis(dimethoxyphosphoryl)propanoic acid
3,3-bis(dimethoxyphosphoryl)-propanoic acid化学式
CAS
959601-54-8
化学式
C7H16O8P2
mdl
——
分子量
290.147
InChiKey
YXZCIPQTTGVZET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    418.3±40.0 °C(Predicted)
  • 密度:
    1.363±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    17
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    108
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    [EN] NOVEL MANGANESE COMPRISING NANOSTRUCTURES
    [FR] NOUVELLES NANOSTRUCTURES COMPORTANT DU MANGANÈSE
    摘要:
    本文披露了包含至少五个伽那双膦酸酯基团的聚合物框架的纳米结构,其中这些伽那双膦酸酯基团独立地被结合为-R3R4C(P=O(OR1)(OR2))2,其中R1和R2分别从阴离子、H、烷基和芳基组成的组中独立选择,且其中R3和R4中至少有一个是连接到聚合物框架的基团,但有一个限制条件,即当R3和R4中仅有一个是这样的连接基团时,另一个R3和R4要么是能够连接到聚合物框架的基团,要么是这种基团的残基,或者从H、OH、OR5和R5组成的组中选择,其中R5是较低的烷基。聚合物框架可能包括锰离子。还披露了制备含锰的纳米结构的方法,包含这种含锰纳米结构的组合物以及使用这种含锰纳米结构,例如作为MRI对比剂。
    公开号:
    WO2013041623A1
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL MANGANESE COMPRISING NANOSTRUCTURES<br/>[FR] NOUVELLES NANOSTRUCTURES COMPORTANT DU MANGANÈSE
    申请人:SPAGO IMAGING AB
    公开号:WO2013041623A1
    公开(公告)日:2013-03-28
    Disclosed herein are nanostructures comprising a polymeric framework comprising at least five geminal bisphosphonate groups, wherein the geminal bisphosphonate groups independently of each other are incorporated as - R3R4C(P=O(OR1)(OR2))2, wherein R1 and R2 are independently selected from the group consisting of a negative charge, H, alkyl and aryl, and wherein at least one of R3 and R4 is a group connected to the polymeric framework with the proviso that when only one of R3 and R4 is such a connected group, the other of R3 and R4 is either a group being able to connect to the polymeric framework, or the residue of such a group, or selected from the group consisting of H, OH, OR5 and R5, wherein R5 is a lower alkyl. The polymeric framework may comprise manganese ions. Disclosed are also methods for producing such manganese containing nanostructures, compositions comprising such manganese containing nanostructures and use of such manganese con¬ taining nanostructures, i.a. as MRI contrasting agents.
    本文披露了包含至少五个伽那双膦酸酯基团的聚合物框架的纳米结构,其中这些伽那双膦酸酯基团独立地被结合为-R3R4C(P=O(OR1)(OR2))2,其中R1和R2分别从阴离子、H、烷基和芳基组成的组中独立选择,且其中R3和R4中至少有一个是连接到聚合物框架的基团,但有一个限制条件,即当R3和R4中仅有一个是这样的连接基团时,另一个R3和R4要么是能够连接到聚合物框架的基团,要么是这种基团的残基,或者从H、OH、OR5和R5组成的组中选择,其中R5是较低的烷基。聚合物框架可能包括锰离子。还披露了制备含锰的纳米结构的方法,包含这种含锰纳米结构的组合物以及使用这种含锰纳米结构,例如作为MRI对比剂。
  • Manganese comprising nanostructures
    申请人:SPAGO IMAGING AB
    公开号:US09040637B2
    公开(公告)日:2015-05-26
    Disclosed herein are nanostructures comprising a polymeric framework comprising at least five geminal bisphosphonate groups, wherein the geminal bisphosphonate groups independently of each other are incorporated as —R3R4C(P═O(OR1)(OR2))2, wherein R1 and R2 are independently selected from the group consisting of a negative charge, H, alkyl and aryl, and wherein at least one of R3 and R4 is a group connected to the polymeric framework with the proviso that when only one of R3 and R4 is such a connected group, the other of R3 and R4 is either a group being able to connect to the polymeric framework, or the residue of such a group, or selected from the group consisting of H, OH, OR5 and R5, wherein R5 is a lower alkyl. The polymeric framework may comprise manganese ions. Disclosed are also methods for producing such manganese containing nanostructures, compositions comprising such manganese containing nanostructures and use of such manganese containing nanostructures, i.a. as MRI contrasting agents.
    本文公开了一种纳米结构,包括至少五个双膦酸酯基团的聚合物框架,其中双膦酸酯基团独立地被并入为—R3R4C(P═O(OR1)(OR2))2,其中R1和R2独立地选择自阴离子、氢、烷基和芳基的群体,而且至少有一个R3和R4是连接到聚合物框架的基团,但当R3和R4中仅有一个是这样的连接基团时,另一个R3和R4则是能够连接到聚合物框架的基团,或者是这样一个基团的残基,或者选择自H、OH、OR5和R5的群体,其中R5是低烷基。聚合物框架可以包括锰离子。还公开了制备这种含锰纳米结构的方法、包含这种含锰纳米结构的组合物以及使用这种含锰纳米结构的方法,其中包括作为MRI对比剂。
  • NOVEL MANGANESE COMPRISING NANOSTRUCTURES
    申请人:SPAGO IMAGING AB
    公开号:US20140350193A1
    公开(公告)日:2014-11-27
    Disclosed herein are nanostructures comprising a polymeric framework comprising at least five geminal bisphosphonate groups, wherein the geminal bisphosphonate groups independently of each other are incorporated as —R 3 R 4 C(P═O(OR 1 )(OR 2 )) 2 , wherein R 1 and R 2 are independently selected from the group consisting of a negative charge, H, alkyl and aryl, and wherein at least one of R 3 and R 4 is a group connected to the polymeric framework with the proviso that when only one of R 3 and R 4 is such a connected group, the other of R 3 and R 4 is either a group being able to connect to the polymeric framework, or the residue of such a group, or selected from the group consisting of H, OH, OR 5 and R 5 , wherein R 5 is a lower alkyl. The polymeric framework may comprise manganese ions. Disclosed are also methods for producing such manganese containing nanostructures, compositions comprising such manganese containing nanostructures and use of such manganese containing nanostructures, i.a. as MRI contrasting agents.
    本文披露了一种纳米结构,包括至少五个双磷酸酯基团的聚合物框架,其中双磷酸酯基团独立地作为-R3R4C(P═O(OR1)(OR2))2并入,其中R1和R2分别选择自阴离子、H、烷基和芳基的群组,而且R3和R4中至少有一个是连接到聚合物框架的群组,但是当R3和R4中仅有一个是这样的连接群组时,另一个则为能够连接到聚合物框架的群组,或是这样的群组的残基,或选择自H、OH、OR5和R5的群组,其中R5是较低的烷基。聚合物框架可以包括锰离子。此外,本文还披露了制备这种含锰纳米结构的方法,包含这种含锰纳米结构的组合物以及使用这种含锰纳米结构的方法,例如作为MRI对比剂。
  • Nanostructures and applications thereof
    申请人:Spago Imaging AB
    公开号:EP2923712A1
    公开(公告)日:2015-09-30
    Disclosed herein are globular nanostructures having a hydrodynamic diameter (Dh) of 8-100 nm comprising a central part and a peripheral part, wherein said central part has a calculated diameter (Dc) of 6-90 nm and said peripheral part has an estimated thickness (Tp) so that Dh=Dc+2Tp, wherein said central part comprises: (i) a crosslinked polymeric framework comprising monomer residues wherein at least 30 % by number of the monomer residues have crosslinked thereby forming the crosslinked polymeric framework and/or (ii) a branched polymeric framework comprising monomer residues wherein the number of branch points is at least 30 % of the number of monomer residues, wherein said central part comprises chelating groups of which at least 4 allow chelation of at least one multiply charged cation, wherein said chelating groups are independently selected from the group consisting of-COOR1, -P=O(OR1)(OR2), and -S(=O)2OR1, wherein R1 and R2 are independently selected from the group consisting of a negative charge, H, and lower alkyls, and wherein said peripheral part comprises a synthetic polymer material covalently attached to the central part, wherein the synthetic polymer material is hydrophilic and bioinert, and electrically neutral or zwitterionic. Also disclosed are compositions comprising such nanoparticles, and optionally also a radionuclide, use of such compositions, kits containing such compositions and methods for obtaining such compositions.
    本文公开了水动力直径(Dh)为 8-100 nm 的球状纳米结构,包括中心部分和外围部分,其中所述中心部分的计算直径(Dc)为 6-90 nm,所述外围部分的估计厚度(Tp)为 Dh=Dc+2Tp,其中所述中心部分包括:(i) 由单体残基组成的交联聚合物框架,其中至少 30% 的单体残基发生交联,从而形成交联聚合物框架和/或 (ii) 支化聚合物框架:(i) 由单体残基组成的交联聚合物框架,其中至少 30% 的单体残基发生交联从而形成交联聚合物框架,和/或 (ii) 由单体残基组成的支化聚合物框架,其中支化点的数量至少为单体残基数量的 30%,其中所述中心部分包括螯合基团,其中至少 4 个螯合基团可螯合至少一个多电荷阳离子、其中所述螯合基团独立地选自-COOR1、-P=O(OR1)(OR2)和-S(=O)2OR1组成的组,其中R1和R2独立地选自负电荷、H和低级烷基组成的组,并且其中所述外围部分包括共价连接到中心部分的合成聚合物材料,其中合成聚合物材料具有亲水性和生物惰性,并且电中性或具有齐聚离子性。此外,还公开了包含此类纳米粒子和放射性核素的组合物、此类组合物的用途、含有此类组合物的试剂盒以及获得此类组合物的方法。
  • MANGANESE COMPRISING NANOSTRUCTURES
    申请人:Spago Nanomedical AB (publ)
    公开号:EP2750716B1
    公开(公告)日:2019-12-25
查看更多

同类化合物

(1-氨基丁基)磷酸 顺丙烯基磷酸 除草剂BUMINAFOS 阿仑膦酸 阻燃剂 FRC-1 铵甲基膦酸盐 钠甲基乙酰基膦酸酯 钆1,5,9-三氮杂环十二烷-N,N',N''-三(亚甲基膦酸) 钆-1,4,7-三氮杂环壬烷-N,N',N''-三(亚甲基膦酸) 重氮甲基膦酸二乙酯 辛基膦酸二丁酯 辛基膦酸 辛基-膦酸二钾盐 辛-1-烯-2-基膦酸 试剂12-Azidododecylphosphonicacid 英卡膦酸 苯胺,4-乙烯基-2-(1-甲基乙基)- 苯甲基膦酸二甲酯 苯基膦酸二甲酯 苯基膦酸二仲丁酯 苯基膦酸二乙酯 苯基膦酸二乙酯 苯基磷酸二辛酯 苯基二异辛基亚磷酸酯 苯基(1H-1,2,4-三唑-1-基)甲基膦酸二乙酯 苯丁酸,b-氨基-g-苯基- 苄基膦酸苄基乙酯 苄基亚甲基二膦酸 膦酸,[(2-乙基己基)亚氨基二(亚甲基)]二,triammonium盐(9CI) 膦酸叔丁酯乙酯 膦酸单十八烷基酯钾盐 膦酸二辛酯 膦酸二(二十一烷基)酯 膦酸,辛基-,单乙基酯 膦酸,甲基-,单(2-乙基己基)酯 膦酸,甲基-,二(苯基甲基)酯 膦酸,甲基-,2-甲氧基乙基1-甲基乙基酯 膦酸,丁基乙基酯 膦酸,[苯基[(苯基甲基)氨基]甲基]-,二甲基酯 膦酸,[[羟基(苯基甲基)氨基]苯基甲基]-,二(苯基甲基)酯 膦酸,[2-(环丙基氨基)-2-羰基乙基]-,二乙基酯 膦酸,[2-(二甲基亚肼基)丙基]-,二乙基酯,(E)- 膦酸,[1-甲基-2-(苯亚氨基)乙烯基]-,二乙基酯 膦酸,[1-(乙酰基氨基)-1-甲基乙基]-(9CI) 膦酸,[(环己基氨基)苯基甲基]-,二乙基酯 膦酸,[(二乙氧基硫膦基)(二甲氨基)甲基]- 膦酸,[(2S)-2-氨基-2-苯基乙基]-,二乙基酯 膦酸,[(1Z)-2-氨基-2-(2-噻嗯基)乙烯基]-,二乙基酯 膦酸,P-[(二乙胺基)羰基]-,二乙基酯 膦酸,(氨基二环丙基甲基)-